Skip to content

Content Header

Medicaid’s Institutions for Mental Disease (IMD) Exclusion – IF10222

Medicaid’s Institutions for Mental Disease (IMD) Exclusion – IF10222 published on

Medicaid is a joint federal-state program that finances the delivery of primary and acute medical services, as well as long-term services and supports, for a diverse low-income population, including children, pregnant women, adults, individuals with disabilities, and people aged 65 and older. (See CRS Report R43357, Medicaid: An Overview.)  Medicaid’s IMD exclusion limits the circumstances under which federal Medicaid matching funds are available for inpatient mental health care. Policymakers have concerns about access to mental health care, and in recent years some have introduced bills to amend or eliminate the IMD exclusion. The scope of the unmet need for inpatient mental health care for individuals with mental illness on Medicaid is unknown, as is the extent to which the need might be met by increasing community-based care or inpatient care in facilities that are not IMDs. 

Date of Report: 5/8/2015
Pages: 2
Order Number: IF10222
Price: $5.95

To Order:  CLICK: HERE  to use the SECURE SHOPPING CART 

Email: congress@pennyhill.com 

Phone: 301-253-0881  

For email and phone orders, provide a Visa, MasterCard, American Express, or Discover card number, expiration date, and name on the card. Indicate whether you want e-mail or postal delivery.

Opioid Treatment Programs and Related Federal Regulations – IF10219

Opioid Treatment Programs and Related Federal Regulations – IF10219 published on

Federally certified opioid treatment programs (OTPs)—also called narcotic treatment programs or, often, methadone clinics—may offer opioid medications, counseling, and other services for individuals addicted to heroin or other opioids. The use of opioid medications to treat opioid addiction is subject to federal regulations beyond those that apply to the same medications used for other purposes (e.g., treating pain). With few exceptions, the use of the opioid medication methadone to treat opioid addiction is limited to OTPs; however, physicians who wish to treat opioid addiction using the opioid medication buprenorphine may obtain a waiver to do so outside an OTP. A non-opioid medication used in the treatment of opioid addiction, naltrexone, may be used by OTPs, physicians with waivers, or anyone with the authority to write prescriptions.

Date of Report: Opioid Treatment Programs and Related Federal Regulations
Pages: 2
Order Number: 5/4/2015
Price: $5.95

To Order:  CLICK: HERE  to use the SECURE SHOPPING CART 

Email: congress@pennyhill.com 

Phone: 301-253-0881  

For email and phone orders, provide a Visa, MasterCard, American Express, or Discover card number, expiration date, and name on the card. Indicate whether you want e-mail or postal delivery.

Primary Sidebar